Fast Market Research

New Market Report Now Available: Dermatologicals in Israel

New Consumer Goods research report from Euromonitor International is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 06/12/2014 -- Like many other OTC consumer health categories in Iran, the official OTC list for dermatologicals contains very few products while a high number of non-OTC alternatives are available. These alternatives include many different types of hair loss treatments which are classified as toiletries to various different forms of antifungals which are not available through OTC channels in Iran. This resulted in relatively low value growth for OTC dermatologicals towards the end of the review period. The category recorded current value growth of 12% in 2013, a slower rate of growth than the 18% current value CAGR recorded in the category over the entire review period. In reality, the consumption of OTC and Rx dermatologicals has increased significantly in Iran in recent years due to the rising awareness of these products among Iranian consumers.

View Full Report Details and Table of Contents

Competitive Landscape

Pak Darou Co remained the leading player in dermatologicals in Iran in 2013 with a 13% value share. This company was followed closely by Tolid Daru Co, also with a 13% value share, and Iran Najo Pharmaceutical Hygienic & Cosmetic Co with 9%. The main reason for the relatively high value shares of Pak Darou Co and Tolid Daru Co is each company's high levels of production of povidone iodine 10% 250ml, which is used widely in Iranian hospitals and clinics as a topical germicidal/antiseptic.

Industry Prospects

Dermatologicals in Ian is expected to increase in value by 1% in constant 2013 terms over the entire forecast period, a slight improvement upon the 2% value decline recorded in the category in constant 2013 terms over the entire review period. Iranian consumers are expected to continue visiting their doctors when faced with a variety of skin problems and this is likely to result in them being given prescriptions for Rx products, negatively impacting sales of OTC dermatologicals over the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Iran with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Iran, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Iran market research report includes:

- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Consumer Goods research reports at Fast Market Research

You may also be interested in these related reports:

- Dermatologicals in the US
- Dermatologicals in Ireland
- Dermatologicals in Japan
- Dermatologicals in Bolivia
- Dermatologicals in Bosnia-Herzegovina
- Dermatologicals in Ukraine
- Dermatologicals in South Korea
- Dermatologicals in the United Arab Emirates
- Dermatologicals in Brazil
- Dermatologicals in Norway